{
  "id": 8148629,
  "title": "ETSA winner Theranautilus heads to human trials; JSW One’s IPO plans",
  "url": "https://urgent.news/2026/09/18/etsa-winner-theranautilus-heads-to-human-trials-jsw-ones-ipo-plans",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-18T02:02:01.000Z",
  "source": {
    "name": "Economic Times Tech",
    "slug": "economic-times-tech",
    "url": "https://economictimes.indiatimes.com/tech/newsletters/morning-dispatch/etsa-winner-theranautilus-heads-to-human-trials-jsw-ones-ipo-plans/articleshow/134323776.cms"
  },
  "original_language": "en",
  "account": "Theranautilus, a Bengaluru-based deeptech startup, is set to commence human trials of its nanorobot-based dental technology in November-December. The trials will begin with 30 patients, followed by a 300-patient multicentric trial, with the goal of commercialisation within two years for oral health and four to five years for oncology applications.",
  "summary": "Happy Friday! Theranautilus is set to begin human trials of its nanorobot-based dental tech soon. This and more in today’s ETtech Morning Dispatch.",
  "key_points": [],
  "editors_take": "Theranautilus's move to human trials marks a significant step towards commercialising its nanorobot-based dental technology, with potential near-term impact on oral health treatment and longer-term implications for oncology applications.",
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}